logo
Plus   Neg
Share
Email

IntelGenx Signs LOI With Tilray To Produce Cannabis-Infused VersaFilm Products

IntelGenx Corp. (IGX.V, IGXT.OB), an oral drug delivery company, announced Thursday that it has executed a non-binding letter of intent or LOI with Tilray, Inc. (TLRY), a cannabis research, cultivation, production and distribution company, to enter into a world-wide agreement to produce cannabis-infused VersaFilm products.

The LOI also contemplates that, at the time of entering into the definitive agreement, Tilray will make a strategic investment in IntelGenx by way of a non-brokered private placement. Tilray will purchase 1.25 million shares of IntelGenx at a price of $0.80 per share, which is equal to the five-day volume weighted average closing price of IntelGenx' common stock on the OTCQX for the period ended September 18.

IntelGenx intends to use the proceeds from the Private Placement for cannabis-infused VersaFilm product development in connection with the LOI. The Private Placement will be subject to the approval of the TSX Venture Exchange.

The companies plan to co-develop and commercialize oral film products infused with recreational and medical cannabis,in anticipation of amended cannabis regulations which would allow adult-use consumers to purchase edible products.

Pursuant to the LOI, subject to entering into a definitive agreement and the satisfaction of customary closing conditions, IntelGenx and Tilray will fund 20% and 80% of the costs associated with the development of the cannabis-infused VersaFilm products, respectively.

IntelGenx will have rights to manufacture and supply the co-developed products to Tilray, and will also receive a fixed single-digit royalty on net product sales. Tilray will have the exclusive, worldwide marketing and distribution rights for the co-developed products.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Two companies have recalled Wintergreen Essential Oil saying the lack of child resistant packaging as required carries the risks of poisoning children, the U.S. Consumer Product Safety Commission stated. Waldo, Wisconsin - based Capstone Holdings LLC is calling back about 2,935 units of Simply Earth Wintergreen Essential Oil that were manufactured in the United States. The U.S. Food and Drug Administration approved Merck & Co. Inc.'s combination antibiotic Recarbrio for the expanded indication in the treatment of adults with hospital-acquired and ventilator-associated bacterial pneumonia (HABP/VABP). The drug had received initial approval in the U.S. in July 2019 to treat patients with complicated urinary tract infections and complicated intra-abdominal infecti Amazon is expanding the aircraft fleet of its air cargo network by leasing 12 additional Boeing 767-300 converted cargo aircraft from Air Transport Services Group Inc. This comes amid increased demand for shipments due to the coronavirus pandemic. These aircraft will join Amazon Air's existing fleet of 70 aircraft to bring its total network to more than 80 aircraft.
Follow RTT